Toll-like receptors (TLRs) are pattern recognition receptors that
activate innate immunity, and their ligands are promising adjuvants
for vaccines and immunotherapies. Small molecule TLR7 ligands are
ideal vaccine adjuvants as they induce not only proinflammatory cytokines
but also type I interferons. However, their application has only been
approved for local administration due to severe systemic immune-related
adverse events. In a previous study, we prepared the gold nanoparticles
coimmobilized with synthetic small molecule TLR7 ligand, 1V209, and
α-mannose (1V209-αMan-GNPs). 1V209-αMan-GNPs were
selectively delivered via a cell surface sugar-binding protein, mannose
receptor, which enabled selective delivery of TLR7 ligands to immune
cells. Besides the mannose receptor, immune cells express various
sugar-binding proteins such as macrophage galactose binding lectins
and sialic acid-binding immunoglobulin-type lectins and recognize
distinct sugar structures. Hence, in the present study, we investigated
whether sugar structures on GNPs affect the efficiency and selectivity
of intracellular delivery and subsequent immunostimulatory potencies.
Five neutral sugars and two sialosides were selected and each sugar
was coimmobilized with 1V209 onto GNPs (1V209-SGNPs) and their innate
immunostimulatory potencies were compared to that of 1V209-αMan-GNPs.
The in vitro study using mouse bone marrow derived
dendritic cells (BMDCs) demonstrated that α-glucose, α-N-acetylglucosamine, or α-fucose immobilized 1V209-SGNPs
increased interleukin-6 and type I interferon release similar to that
of 1V209-αMan-GNPs, whereas galacto-type sugar immobilized 1V209-SGNPs
predominantly enhanced type I interferon release. In contrast, sialoside
immobilized 1V209-SGNPs did not enhance the potency of 1V209. In the in vivo immunization study using ovalbumin as a model antigen,
neutral sugar immobilized 1V209-SGNPs induced comparable T helper-1
immune response to that of 1V209-αMan-GNPs and by 10-fold higher
than that of sialoside immobilized 1V209-SGNPs. These results indicate
that the sugar structures on 1V209-SGNPs affect their immunostimulatory
activities, and functionalization of the carrier particles is important
to shape immune responses.